AI assistant
AMGEN INC — Director's Dealing 2024
Dec 4, 2024
29819_dirs_2024-12-03_8455636f-4fd2-4ff0-86f6-121910d227e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2024-12-02
Reporting Person: Bradway Robert A (Director, Chairman, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-02 | Common Stock | G | 96000 | — | Disposed | 573855 | Direct |
| 2024-12-02 | Common Stock | G | 90000 | — | Acquired | 90000 | Indirect |
| 2024-12-02 | Common Stock | G | 90000 | — | Disposed | 393855 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 90000 | Indirect |
Footnotes
F1: These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's children, subsequent to the same-day transfer by the reporting person of 48,000 shares as separate property of the reporting person's spouse. Neither the reporting person nor the reporting person's spouse are trustees of the children's trusts or otherwise have the power to vote or dispose of the assets held in such trusts.
F2: On 12/2/2024, the reporting person contributed 90,000 shares to the reporting person's grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.
F3: Subsequent to the same-day transfer by the reporting person of 90,000 shares as separate property of the reporting person's spouse, such shares were contributed to a spousal grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person's spouse is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.
F4: Shares directly beneficially owned also include 2,141 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.